Syneos Health: Accelerating Drug Development Through Integrated Solutions
Syneos Health is a leading, fully-integrated biopharmaceutical solutions organization dedicated to accelerating customer success. The company partners with innovators throughout the entire drug development and commercialization process, navigating complexity and driving progress for its clients. With a focus on clinical development, Syneos Health leverages decades of experience and cutting-edge technology to bring life-changing medicines to patients faster.
A Comprehensive Suite of Clinical Development Services
Syneos Health offers a broad spectrum of clinical trial services, encompassing all phases of development – from Early Phase studies to Phase II-IV trials and Real World Evidence (RWE) generation. These services are designed to adapt to the unique needs of each program, providing strategic clinical planning and global trial execution. Learn more about their clinical development solutions.
Leveraging AI and Technology for Efficiency
Recognizing the inefficiencies inherent in traditional clinical trial processes, Syneos Health is at the forefront of integrating artificial intelligence (AI) and advanced technologies. The company has developed a unified data solution in Microsoft Azure and is utilizing Azure OpenAI Service to enhance data analysis capabilities. This initiative has already yielded significant results, including reduced clinical trial site activation times and improved predictive modeling.
Syneos Health by the Numbers
Syneos Health’s extensive experience and expertise are reflected in its impressive track record:
- 40+ years of clinical trial experience
- 480+ Medical Doctors (MDs)
- 750+ PhDs with deep therapeutic, scientific and operational expertise
- 100+ years of combined advocacy and patient affairs experience
- In the last five years, Syneos Health has contributed to the development or commercialization of a significant portion of novel drugs approved by the US Food and Drug Administration (FDA) and products authorized by the European Medicines Agency (EMA).
Strategic Partnerships and Flexible Outsourcing Models
Syneos Health offers both full-service clinical development solutions and Functional Service Provider (FSP) 360 models, providing clients with flexibility and customization. Whether through a comprehensive partnership or a targeted outsourcing approach, Syneos Health collaborates with clients to achieve their goals. Explore partnership options.
Commitment to Innovation and Employee Development
Syneos Health fosters a culture of innovation and continuous improvement, investing in the development of its 25,000+ colleagues. The company prioritizes career progression, technical training, and a supportive work environment. This commitment extends to building an inclusive culture where employees can authentically be themselves. Learn more about Syneos Health’s culture.
Recent Achievements and Impact
Over the past five years, Syneos Health has been involved in 94% of all Novel FDA Approved Drugs, 95% of EMA Authorized Products, and over 200 Studies across 73,000 Sites and 675,000+ Trial patients. Visit the Syneos Health website.
The company’s dedication to streamlining processes and embracing recent technologies positions it as a key player in accelerating the delivery of critical medicines to patients worldwide.